Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 50% · prior close shown (market closed)
Limited proprietary earnings coverage for CLYM yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 34d ago
Updated
What happened recently for Climb Bio, Inc. (CLYM) — events, not interpretation.
Research & analysis only — not investment advice.
Prior close
$16.33
Market cap
$937.93M
Profitable
—
Net income
—
FY Aug 15, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Climb Bio, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Climb Bio, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.